Description: As the insurance industry continues to rapidly evolve through influences of InsurTech, it is increasingly important for actuaries to be informed regarding InsurTech. According to a recent study, approximately 16 percent of all InsurTech companies are in the life insurance business. Major areas of focus have included pricing, policy administration as well as marketing, distribution and sales. The changes coming about through InsurTech impact actuaries directly. I Keep current by being informed regarding InsurTech activity. By attending the session, you will: - Learn about the latest developments in life insurance and annuities in InsurTech.

Description: Every year an AI topic goes through a hype cycle. Since 2022 and now in 2023 we continue to hear more about the ChatGPT models and how an everyday person is able to interact with AI. As more startups and applications are riding the hype, what does it all mean for our industry? Is this just a buzz or real? This talk intends to cover at a high level what are large language models, what does it mean for audit or regulatory space, and what might be some pitfalls or tolerance of error when it comes to selecting a right application for such models in insurance use cases.

Description: New digital data known as alternative data is everywhere. Our industry has seen the financial, and hi-tech industries leverage new digital data to expand their key offerings and core services. From the lens of the global life and health industry, new digital data is still searching to be further understood. Risk assessment is a current focus area for using alternative data. A key question is even though risk assessment has always been data-driven, can it now move to the next level with the arrival of this alternative data. Can we use alternative data to make the risk assessment process quicker, cheaper, or faster thereby driving more sales and better conversion rates. It is an exciting time! With the increased adoption of health and well-being apps, data such as physical activity, nutrition, sleep, and mental wellness is now readily available. Expanded data such as digital biomarkers, IoT data, electronic health records and many more can also be accessed. However, how to effectively implement alternative data remains a challenge across the industry. We firmly believe it is, and will continue to be, imperative to take a structured approach to alternative data through a set of key considerations and a framework of principles.

Description: You’ve written the position papers, updated the models, and designed the required disclosures, but you may be wondering how to explain the results during interim financial reporting periods to company management as well as other stakeholders. This session will explore ways to adapt existing management reporting and offer ideas for new metrics. We will explore various methods for analyzing DAC amortization patterns, market risk benefit reserve patterns, and Liability for Future Benefits (LFPB) movements. In addition, this session will explore ways to integrate changes in LDTI with business planning and other broader business issues such as product pricing considerations and reinsurance strategy.